Purchases and Sales Made in Q2 2023 in Mersana Therapeutics, Inc. (MRSN)
This table provides information about the institutional ownership of Mersana Therapeutics, Inc. (MRSN) during Q2 2023. The information is specifically focused on institutions that hold shares of Mersana Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2023
Q2 2023
|
Delphia (Usa) Inc.
Toronto, A6 |
SELL
|
- |
-7.37K- 30.26% |
$22.7K - $70.4K
|
17K
$10.4K
|
|
Aug 11, 2023
Q2 2023
|
E Fund Management Co., Ltd.
Guangzhou, F4 |
SELL
|
- |
-9.47K- 34.35% |
$29.2K - $90.5K
|
18.1K
$11K
|
|
Aug 14, 2023
Q2 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-9.81K- 0.85% |
$30.2K - $93.7K
|
1.14M
$694K
|
|
Aug 03, 2023
Q2 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-11.1K- 5.61% |
$34.2K - $106K
|
187K
$114K
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-11.8K- 6.35% |
$36.3K - $113K
|
174K
$106K
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-16K- 68.43% |
$49.4K - $153K
|
7.4K
$4.52K
|
|
Aug 10, 2023
Q2 2023
|
Profund Advisors LLC
|
SELL
|
- |
-28.3K- 31.42% |
$87.2K - $270K
|
61.8K
$37.7K
|
|
Aug 14, 2023
Q2 2023
|
Engineers Gate Manager LP
New York, NY |
SELL
|
- |
-28.4K- 41.09% |
$87.5K - $271K
|
40.7K
$24.9K
|
|
Aug 14, 2023
Q2 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-47.7K- 18.94% |
$147K - $455K
|
204K
$125K
|
|
Oct 21, 2024
Q2 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-58.2K- 72.21% |
$179K - $556K
|
22.4K
$13.7K
|
|
Aug 14, 2023
Q2 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-68.5K- 30.66% |
$211K - $654K
|
155K
$94.5K
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-113K- 99.93% |
$347K - $1.08M
|
76
$46.4
|
|
Aug 14, 2023
Q2 2023
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
- |
-115K- 38.83% |
$354K - $1.1M
|
181K
$110K
|
|
Aug 14, 2023
Q2 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-125K- 40.05% |
$384K - $1.19M
|
186K
$114K
|
|
Aug 11, 2023
Q2 2023
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-149K- 30.69% |
$459K - $1.42M
|
337K
$205K
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-203K- 16.2% |
$624K - $1.93M
|
1.05M
$639K
|
|
Aug 14, 2023
Q2 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-226K- 28.14% |
$697K - $2.16M
|
578K
$353K
|
|
Aug 09, 2023
Q2 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-230K- 54.78% |
$708K - $2.19M
|
190K
$116K
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-294K- 70.04% |
$904K - $2.8M
|
126K
$76.6K
|
|
Aug 14, 2023
Q2 2023
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-445K- 88.71% |
$1.37M - $4.25M
|
56.7K
$34.6K
|
|
Aug 08, 2023
Q2 2023
|
Candriam S.C.A.
|
SELL
|
- |
-547K- 18.47% |
$1.69M - $5.23M
|
2.42M
$1.47M
|
|
Aug 14, 2023
Q2 2023
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-701K- 17.07% |
$2.16M - $6.69M
|
3.4M
$2.08M
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-714K- 70.32% |
$2.2M - $6.82M
|
301K
$184K
|
|
Aug 14, 2023
Q2 2023
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-800K- 42.42% |
$2.46M - $7.64M
|
1.09M
$663K
|
|
Aug 14, 2023
Q2 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-820K- 45.42% |
$2.53M - $7.83M
|
986K
$601K
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.13M- 59.73% |
$3.49M - $10.8M
|
765K
$466K
|
|
Aug 14, 2023
Q2 2023
|
Sarissa Capital Management LP
Greenwich, CT |
SELL
|
- |
-1.17M- 30.71% |
$3.59M - $11.1M
|
2.63M
$1.61M
|
|
Aug 14, 2023
Q2 2023
|
Avoro Capital Advisors LLC
New York, NY |
SELL
|
- |
-1.18M- 15.56% |
$3.62M - $11.2M
|
6.38M
$3.89M
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.51M- 23.5% |
$4.64M - $14.4M
|
4.91M
$2.99M
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.54M- 52.51% |
$4.75M - $14.7M
|
1.4M
$852K
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.54M- 52.51% |
$4.75M - $14.7M
|
1.4M
$852K
|
|
Aug 14, 2023
Q2 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-1.8M- 19.94% |
$5.53M - $17.2M
|
7.21M
$4.4M
|